TownSquare Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.77M | Sell |
198,256
-2,139
| -1% | -$56K | 0.88% | 33 |
|
|
2026
Q1 | $5.63M | Buy |
200,395
+67,796
| +51% | +$1.8M | 1.27% | 22 |
|
|
2025
Q4 | $3.3M | Sell |
132,599
-72,177
| -35% | -$1.82M | 0.74% | 34 |
|
|
2025
Q3 | $5.22M | Buy |
204,776
+511
| +0.3% | +$12.6K | 0.79% | 31 |
|
|
2025
Q2 | $4.95M | Sell |
204,265
-345,427
| -63% | -$8.06M | 0.48% | 52 |
|
|
2025
Q1 | $13.9M | Buy |
549,692
+140,342
| +34% | +$3.67M | 0.15% | 130 |
|
|
2024
Q4 | $10.9M | Sell |
409,350
-333,364
| -45% | -$9.04M | 0.12% | 148 |
|
|
2024
Q3 | $21.5M | Buy |
742,714
+166,709
| +29% | +$4.86M | 0.26% | 79 |
|
|
2024
Q2 | $16.1M | Buy |
576,005
+47,920
| +9% | +$1.32M | 0.22% | 92 |
|
|
2024
Q1 | $14.7M | Buy |
528,085
+322,235
| +157% | +$8.94M | 0.21% | 100 |
|
|
2023
Q4 | $5.93M | Sell |
205,850
-158,568
| -44% | -$4.79M | 0.1% | 190 |
|
|
2023
Q3 | $12.1M | Buy |
364,418
+9,121
| +3% | +$323K | 0.22% | 97 |
|
|
2023
Q2 | $13M | Buy |
355,297
+87,451
| +33% | +$3.4M | 0.24% | 87 |
|
|
2023
Q1 | $10.9M | Buy |
267,846
+20,172
| +8% | +$871K | 0.24% | 85 |
|
|
2022
Q4 | $12.7M | Buy |
247,674
+25,126
| +11% | +$1.2M | 0.31% | 72 |
|
|
2022
Q3 | $9.74M | Buy |
222,548
+10,356
| +5% | +$503K | 0.28% | 74 |
|
|
2022
Q2 | $11.1M | Buy |
212,192
+28,849
| +16% | +$1.47M | 0.32% | 65 |
|
|
2022
Q1 | $9.49M | Sell |
183,343
-30,724
| -14% | -$1.59M | 0.24% | 78 |
|
|
2021
Q4 | $12.6M | Buy |
214,067
+41,548
| +24% | +$2.06M | 0.32% | 67 |
|
|
2021
Q3 | $7.42M | Buy |
172,519
+47,177
| +38% | +$2.09M | 0.21% | 87 |
|
|
2021
Q2 | $4.92M | Buy |
125,342
+11,763
| +10% | +$457K | 0.16% | 114 |
|
|
2021
Q1 | $4.12M | Buy |
113,579
+7,163
| +7% | +$254K | 0.16% | 115 |
|
|
2020
Q4 | $3.92M | Buy |
106,416
+375
| +0.4% | +$13.8K | 0.17% | 113 |
|
|
2020
Q3 | $3.64M | Buy |
106,041
+2,549
| +2% | +$89.4K | 0.21% | 99 |
|
|
2020
Q2 | $3.46M | Sell |
103,492
-7,131
| -6% | -$242K | 0.23% | 84 |
|
|
2020
Q1 | $3.95M | Buy |
110,623
+21,583
| +24% | +$735K | 0.32% | 64 |
|
|
2019
Q4 | $3.31M | Buy |
89,040
+357
| +0.4% | +$12.7K | 0.27% | 76 |
|
|
2019
Q3 | $3.11M | Buy |
88,683
+2,066
| +2% | +$75.1K | 0.26% | 83 |
|
|
2019
Q2 | $3.12M | Sell |
86,617
-8,709
| -9% | -$346K | 0.3% | 66 |
|
|
2019
Q1 | $3.84M | Buy |
95,326
+25,766
| +37% | +$1.03M | 0.3% | 76 |
|
|
2018
Q4 | $2.78M | Buy |
+69,560
| New | +$2.89M | 0.36% | 60 |
|
Other funds holding PFE
TownSquare Capital's PFE Position: Q2 2026 in Review
TownSquare Capital reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $56K and leaving 198,256 shares worth $4.77M. The position accounts for 0.88% of the portfolio, ranked #33.
TownSquare Capital first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $21.5M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- TownSquare Capital held 198,256 shares of Pfizer worth $4.77M as of Q2 2026.
- TownSquare Capital sold 2,139 Pfizer shares in Q2 2026, an estimated $56K.
- Pfizer made up 0.88% of TownSquare Capital's portfolio in Q2 2026, its #33 holding.
- TownSquare Capital first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- TownSquare Capital's Pfizer position peaked at $21.5M in Q3 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.